查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1375922

多组学市场规模、份额和趋势分析报告：按产品/服务、类型、平台、最终用途、地区和细分趋势，2023-2030

Multiomics Market Size, Share & Trends Analysis Report By Product & Service (Instruments, Consumables), By Type (Single-cell, Bulk), By Platform, By Application, By End-use, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 180 Pages | 商品交期: 2-10个工作天内

价格

多组学市场成长与趋势：

Grand View Research, Inc.最新报告显示，预计到2030年，全球多组学市场规模将达到63.8亿美元，2023年至2030年年复合成长率为15.3%。

组学技术成本下降以及私人和公共机构投资和资金筹措增加等因素预计将推动市场发展。由于製药公司、生技公司和学术研究机构的需求不断增加，市场竞争日益激烈，预计也将在预测期内推动市场成长。

随着技术的进步，组学技术的成本预计会降低，使研究人员更容易获得资料，从而推动市场成长。公司正在专注于技术进步以降低成本。例如，Amazon Web Services 于 2022 年 11 月宣布推出 Amazon Omics Services。该服务利用生物资讯学友善的储存选项来储存原始序列资料并降低成本。因此，较低的成本预计将使研究人员和临床医生更容易获得组学技术。这种成本的降低预计将增加多组学方法的采用。

私人和公共参与者增加的投资和资金预计将增加对多组学产品和服务的需求。多家公司正大力投资开发多组学平台和技术。例如，2022年1月，罗氏向生技公司Freenome投资2.9亿美元。该投资用于加速该公司用于早期癌症检测的多组学平台。此外，2023 年 5 月，MultiOmic Health 完成了 620 万美元的资金筹措，用于建立精准治疗药物发现平台。因此，由于资金筹措和投资的增加，新兴市场预计将开发各种新平台和产品。

市场相关人员日益关注开发创新产品和服务也是推动市场需求成长的关键因素。为了应对日益激烈的竞争，各公司正在开发新颖的平台。例如，2023 年 2 月，Via Scientific, Inc. 宣布推出 Foundry，这是一个多组学加速器平台，支援多组学研究期间复杂资料和分析任务的自动化。预计此类产品的推出将在预测期内推动该行业的发展。

多组学市场报告亮点

  • 按产品/服务划分，产品领域在市场中占据主导地位，2022年销售份额将达到60.5%，这是由于设备和软体等产品的推出不断增加。
  • 按类型划分，批量多组学是业界最大的收益贡献者。另一方面，由于对单细胞多组学理解复杂生物系统的需求不断增加，单细胞多组学预计在预测期内将以 17.8% 的年复合成长率增长最快。
  • 按平台划分，基因组学占据市场主导地位，2022 年销售额份额为 40.6%。这种增长是由于该细分市场提供了大量产品。
  • 从应用来看，细胞生物学领域到2022年将占据38.8%的份额，占据全球产业主导地位。相反，预计肿瘤学领域在预测期内将达到最高成长率。
  • 按最终用途划分，学术和研究机构部门是业界最大的收益贡献者，份额为 50.7%。相较之下，由于对多组学加速药物研发发现和开发的需求不断增加，製药和生物技术公司预计将成长最快。
  • 由于该地区主要市场参与者的存在，北美在 2022 年以 48.45% 的收益占有率主导全球产业。

目录

第1章调查方法与范围

第2章执行摘要

第3章市场变数、趋势和范围

  • 市场体系展望
  • 市场动态
  • 产业分析工具

第4章产品和服务的业务分析

  • 多组学市场：产品与服务变化分析
  • 产品
    • 产品市场，2018-2030
    • 乐器
    • 消耗品
    • 软体
  • 服务
    • 服务市场，2018-2030

第5章业务分析类型

  • 多组学市场：类型变异分析
  • 单细胞多组学
  • 批量多组学

第6章平台业务分析

  • 多组学市场：平台波动分析
  • 基因组学
    • 基因组学市场，2018-2030
  • 转录组学
    • 转录组学市场，2018-2030
  • 蛋白质体学
    • 蛋白质体学市场，2018-2030
  • 代谢组学
    • 代谢组学市场，2018-2030
  • 整合组学平台
    • 整合组学平台市场，2018-2030

第7章应用业务分析

  • 多组学市场：应用变化分析
  • 细胞生物学
  • 肿瘤学
  • 神经病学
  • 免疫学

第8章最终用途业务分析

  • 多组学市场：最终用途变异分析
  • 学术研究所
    • 学术研究机构市场，2018-2030
  • 製药和生物技术公司
    • 製药和生物技术公司市场，2018-2030
  • 其他的
    • 其他市场，2018-2030

第9章区域业务分析

  • 2022 年和 2030 年按地区分類的多组学市场占有率
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东/非洲

第10章竞争形势

  • 公司分类
  • 策略规划
  • 2022 年企业市场分析
  • 公司简介/名单
    • BD
    • Thermo Fisher Scientific, Inc,
    • Illumina
    • Danaher
    • PerkinElmer
    • Shimadzu Corporation
    • Bruker
    • QIAGEN
    • Agilent Technologies
    • BGI
Product Code: GVR-4-68040-136-5

Multiomics Market Growth & Trends:

The global multiomics market size is expected to reach USD 6.38 billion by 2030, registering a CAGR of 15.3% from 2023 to 2030, according to a new report by Grand View Research, Inc.. Factors such as the decreasing costs of omics technologies and growing investment and funding from private and public players are expected to drive the market. In addition, rising competition in the market owing to increasing demand from pharmaceutical & biotechnology companies and academic research institutions is also anticipated to propel the market growth over the forecast period.

With the improvement in technologies, the cost of omics technologies is anticipated to reduce, which can increase the accessibility of datasets to researchers, consequently driving market growth. Companies are focusing on technological advancements to lower costs. For instance, in November 2022, Amazon Web Services introduced an Amazon Omics service. This service utilizes bioinformatics-aware storage options to store raw sequence data and to decrease costs. Thus, the decreasing costs are anticipated to increase the accessibility of omics technologies to researchers and clinicians. Such cost reduction is expected to increase the adoption of multiomics approaches.

The growing investments and funding from private and public participants are anticipated to boost the demand for multi-omics products and services. Various companies are significantly investing in the development of multiomics platforms and technologies. For instance, in January 2022, Roche invested USD 290 million in Freenome, a biotech company. This investment was used to accelerate multiomics platforms for early cancer detection. In addition, in May 2023, MultiOmic Health completed a funding round of USD 6.2 million to construct a precision therapeutics discovery platform. Thus, the rising funding and investments are expected to develop various novel platforms and products in the markets

The rising emphasis of market players to develop innovative products and services is another vital factor propelling market demand forward. Various companies are developing novel platforms to sustain the rising competition. For instance, in February 2023, Via Scientific, Inc. introduced a multi-omics accelerator platform, Foundry, that supports the automation of complex data and analytical work during multi-omics research. Such product launches are anticipated to drive the industry over the forecast period.

Multiomics Market Report Highlights:

  • Based on product & service, the product segment dominated the market with a revenue share of 60.5% in 2022, which can be attributed to the rising launches of products such as instruments and software
  • Based on type, the bulk multiomics held the largest revenue contributor for the industry. In contrast, single-cell multi-omics is expected to grow at the fastest CAGR of 17.8% over the forecast period, due to increasing demand for single-cell multi-omics to comprehend complex biology systems
  • Based on platform, genomics dominated the market with a revenue share of 40.6% in 2022. The growth is attributed to the high number of products available in this segment
  • Based on application, the cell biology segment dominated the global industry with a share of 38.8% in 2022. In contrast, the oncology segment is projected to register the highest growth rate during the projected period
  • Based on end-use, the academic and research institute segment was the largest revenue contributor for the industry, with a share of 50.7%. In contrast, pharmaceutical and biotechnology companies are expected to witness the fastest growth owing to increasing demand for multi-omics to accelerate drug discovery and development
  • North America dominated the global industry in 2022 with a revenue share of 48.45%, owing to the presence of key market players in the region

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Information Analysis
    • 1.2.2. Market Platform & Data Visualization
    • 1.2.3. Data Validation & Publishing
  • 1.3. Research Assumptions
  • 1.4. Information Procurement
    • 1.4.1. Primary Research
  • 1.5. Information or Data Analysis
  • 1.6. Market Platform & Validation
  • 1.7. Market Model
  • 1.8. Global Market: CAGR Calculation
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing demand for single cell omics
      • 3.2.1.2. Advancements in omics technology and decreasing costs of omics technologies
      • 3.2.1.3. Increasing investments and funding from private and public players
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Challenges in multiomics data integration and data complexity
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Product & Service Business Analysis

  • 4.1. Multiomics Market: Product & Service Movement Analysis
  • 4.2. Products
    • 4.2.1. Products Market, 2018 - 2030 (USD Million)
    • 4.2.2. Instruments
      • 4.2.2.1. Instruments Market, 2018 - 2030 (USD Million)
    • 4.2.3. Consumables
      • 4.2.3.1. Consumables Market, 2018 - 2030 (USD Million)
    • 4.2.4. Software
      • 4.2.4.1. Software Market, 2018 - 2030 (USD Million)
  • 4.3. Services
    • 4.3.1. Services Market, 2018 - 2030 (USD Million)

Chapter 5. Type Business Analysis

  • 5.1. Multiomics Market: Type Movement Analysis
  • 5.2. Single- Cell Multiomics
    • 5.2.1. Single- Cell Multiomics Market, 2018 - 2030 (USD Million)
  • 5.3. Bulk Multiomics
    • 5.3.1. Bulk Multiomics Market, 2018 - 2030 (USD Million)

Chapter 6. Platform Business Analysis

  • 6.1. Multiomics Market: Platform Movement Analysis
  • 6.2. Genomics
    • 6.2.1. Genomics Market, 2018 - 2030 (USD Million)
  • 6.3. Transcriptomics
    • 6.3.1. Transcriptomics Market, 2018 - 2030 (USD Million)
  • 6.4. Proteomics
    • 6.4.1. Proteomics Market, 2018 - 2030 (USD Million)
  • 6.5. Metabolomics
    • 6.5.1. Metabolomics Market, 2018 - 2030 (USD Million)
  • 6.6. Integrated Omics Platforms
    • 6.6.1. Integrated Omics Platforms Market, 2018 - 2030 (USD Million)

Chapter 7. Application Business Analysis

  • 7.1. Multiomics Market: Application Movement Analysis
  • 7.2. Cell Biology
    • 7.2.1. Cell Biology Market, 2018 - 2030 (USD Million)
  • 7.3. Oncology
    • 7.3.1. Oncology Market, 2018 - 2030 (USD Million)
  • 7.4. Neurology
    • 7.4.1. Neurology Market, 2018 - 2030 (USD Million)
  • 7.5. Immunology
    • 7.5.1. Immunology Market, 2018 - 2030 (USD Million)

Chapter 8. End-use Business Analysis

  • 8.1. Multiomics Market: End-use Movement Analysis
  • 8.2. Academic and Research Institutes
    • 8.2.1. Academic and Research Institutes Market, 2018 - 2030 (USD Million)
  • 8.3. Pharmaceutical & Biotechnology Companies
    • 8.3.1. Pharmaceutical & Biotechnology Companies Market, 2018 - 2030 (USD Million)
  • 8.4. Others
    • 8.4.1. Others Market, 2018 - 2030 (USD Million)

Chapter 9. Regional Business Analysis

  • 9.1. Multiomics Market Share By Region, 2022 & 2030
  • 9.2. North America
    • 9.2.1. North America Multiomics Market, 2018 - 2030 (USD Million)
    • 9.2.2. U.S.
      • 9.2.2.1. Key Country Dynamics
      • 9.2.2.2. Target Disease Prevalence
      • 9.2.2.3. Competitive Scenario
      • 9.2.2.4. U.S. Multiomics Market, 2018 - 2030 (USD Million)
    • 9.2.3. Canada
      • 9.2.3.1. Key Country Dynamics
      • 9.2.3.2. Target Disease Prevalence
      • 9.2.3.3. Competitive Scenario
      • 9.2.3.4. Canada Multiomics Market, 2018 - 2030 (USD Million)
  • 9.3. Europe
    • 9.3.1. Europe Multiomics Market, 2018 - 2030 (USD Million)
    • 9.3.2. UK
      • 9.3.2.1. Key Country Dynamics
      • 9.3.2.2. Target Disease Prevalence
      • 9.3.2.3. Competitive Scenario
      • 9.3.2.4. UK Multiomics Market, 2018 - 2030 (USD Million)
    • 9.3.3. Germany
      • 9.3.3.1. Key Country Dynamics
      • 9.3.3.2. Target Disease Prevalence
      • 9.3.3.3. Competitive Scenario
      • 9.3.3.4. Germany Multiomics Market, 2018 - 2030 (USD Million)
    • 9.3.4. France
      • 9.3.4.1. Key Country Dynamics
      • 9.3.4.2. Target Disease Prevalence
      • 9.3.4.3. Competitive Scenario
      • 9.3.4.4. France Multiomics Market, 2018 - 2030 (USD Million)
    • 9.3.5. Italy
      • 9.3.5.1. Key Country Dynamics
      • 9.3.5.2. Target Disease Prevalence
      • 9.3.5.3. Competitive Scenario
      • 9.3.5.4. Italy Multiomics Market, 2018 - 2030 (USD Million)
    • 9.3.6. Spain
      • 9.3.6.1. Key Country Dynamics
      • 9.3.6.2. Target Disease Prevalence
      • 9.3.6.3. Competitive Scenario
      • 9.3.6.4. Spain Multiomics Market, 2018 - 2030 (USD Million)
    • 9.3.7. Denmark
      • 9.3.7.1. Key Country Dynamics
      • 9.3.7.2. Target Disease Prevalence
      • 9.3.7.3. Competitive Scenario
      • 9.3.7.4. Denmark Multiomics Market, 2018 - 2030 (USD Million)
    • 9.3.8. Sweden
      • 9.3.8.1. Key Country Dynamics
      • 9.3.8.2. Target Disease Prevalence
      • 9.3.8.3. Competitive Scenario
      • 9.3.8.4. Sweden Multiomics Market, 2018 - 2030 (USD Million)
    • 9.3.9. Norway
      • 9.3.9.1. Key Country Dynamics
      • 9.3.9.2. Target Disease Prevalence
      • 9.3.9.3. Competitive Scenario
      • 9.3.9.4. Norway Multiomics Market, 2018 - 2030 (USD Million)
  • 9.4. Asia Pacific
    • 9.4.1. Asia Pacific Multiomics Market, 2018 - 2030 (USD Million)
    • 9.4.2. Japan
      • 9.4.2.1. Key Country Dynamics
      • 9.4.2.2. Target Disease Prevalence
      • 9.4.2.3. Competitive Scenario
      • 9.4.2.4. Japan Multiomics Market, 2018 - 2030 (USD Million)
    • 9.4.3. China
      • 9.4.3.1. Key Country Dynamics
      • 9.4.3.2. Target Disease Prevalence
      • 9.4.3.3. Competitive Scenario
      • 9.4.3.4. China Multiomics Market, 2018 - 2030 (USD Million)
    • 9.4.4. India
      • 9.4.4.1. Key Country Dynamics
      • 9.4.4.2. Target Disease Prevalence
      • 9.4.4.3. Competitive Scenario
      • 9.4.4.4. India Multiomics Market, 2018 - 2030 (USD Million)
    • 9.4.5. Australia
      • 9.4.5.1. Key Country Dynamics
      • 9.4.5.2. Target Disease Prevalence
      • 9.4.5.3. Competitive Scenario
      • 9.4.5.4. Australia Multiomics Market, 2018 - 2030 (USD Million)
    • 9.4.6. Thailand
      • 9.4.6.1. Key Country Dynamics
      • 9.4.6.2. Target Disease Prevalence
      • 9.4.6.3. Competitive Scenario
      • 9.4.6.4. Thailand Multiomics Market, 2018 - 2030 (USD Million)
    • 9.4.7. South Korea
      • 9.4.7.1. Key Country Dynamics
      • 9.4.7.2. Target Disease Prevalence
      • 9.4.7.3. Competitive Scenario
      • 9.4.7.4. South Korea Multiomics Market, 2018 - 2030 (USD Million)
  • 9.5. Latin America
    • 9.5.1. Latin America Multiomics Market, 2018 - 2030 (USD Million)
    • 9.5.2. Brazil
      • 9.5.2.1. Key Country Dynamics
      • 9.5.2.2. Target Disease Prevalence
      • 9.5.2.3. Competitive Scenario
      • 9.5.2.4. Brazil Multiomics Market, 2018 - 2030 (USD Million)
    • 9.5.3. Mexico
      • 9.5.3.1. Key Country Dynamics
      • 9.5.3.2. Target Disease Prevalence
      • 9.5.3.3. Competitive Scenario
      • 9.5.3.4. Mexico Multiomics Market, 2018 - 2030 (USD Million)
    • 9.5.4. Argentina
      • 9.5.4.1. Key Country Dynamics
      • 9.5.4.2. Target Disease Prevalence
      • 9.5.4.3. Competitive Scenario
      • 9.5.4.4. Argentina Multiomics Market, 2018 - 2030 (USD Million)
  • 9.6. MEA
    • 9.6.1. MEA Multiomics Market, 2018 - 2030 (USD Million)
    • 9.6.2. South Africa
      • 9.6.2.1. Key Country Dynamics
      • 9.6.2.2. Target Disease Prevalence
      • 9.6.2.3. Competitive Scenario
      • 9.6.2.4. South Africa Multiomics Market, 2018 - 2030 (USD Million)
    • 9.6.3. Saudi Arabia
      • 9.6.3.1. Key Country Dynamics
      • 9.6.3.2. Target Disease Prevalence
      • 9.6.3.3. Competitive Scenario
      • 9.6.3.4. Saudi Arabia Multiomics Market, 2018 - 2030 (USD Million)
    • 9.6.4. UAE
      • 9.6.4.1. Key Country Dynamics
      • 9.6.4.2. Target Disease Prevalence
      • 9.6.4.3. Competitive Scenario
      • 9.6.4.4. UAE Multiomics Market, 2018 - 2030 (USD Million)
    • 9.6.5. Kuwait
      • 9.6.5.1. Key Country Dynamics
      • 9.6.5.2. Target Disease Prevalence
      • 9.6.5.3. Competitive Scenario
      • 9.6.5.4. Kuwait Multiomics Market, 2018 - 2030 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Company Categorization
  • 10.2. Strategy Mapping
  • 10.3. Company Market Position Analysis, 2022
  • 10.4. Company Profiles/Listing
    • 10.4.1. BD
      • 10.4.1.1. Overview
      • 10.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 10.4.1.3. Product Benchmarking
      • 10.4.1.4. Strategic Initiatives
    • 10.4.2. Thermo Fisher Scientific, Inc,
      • 10.4.2.1. Overview
      • 10.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 10.4.2.3. Product Benchmarking
      • 10.4.2.4. Strategic Initiatives
    • 10.4.3. Illumina
      • 10.4.3.1. Overview
      • 10.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 10.4.3.3. Product Benchmarking
      • 10.4.3.4. Strategic Initiatives
    • 10.4.4. Danaher
      • 10.4.4.1. Overview
      • 10.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 10.4.4.3. Product Benchmarking
      • 10.4.4.4. Strategic Initiatives
    • 10.4.5. PerkinElmer
      • 10.4.5.1. Overview
      • 10.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 10.4.5.3. Product Benchmarking
      • 10.4.5.4. Strategic Initiatives
    • 10.4.6. Shimadzu Corporation
      • 10.4.6.1. Overview
      • 10.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 10.4.6.3. Product Benchmarking
      • 10.4.6.4. Strategic Initiatives
    • 10.4.7. Bruker
      • 10.4.7.1. Overview
      • 10.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 10.4.7.3. Product Benchmarking
      • 10.4.7.4. Strategic Initiatives
    • 10.4.8. QIAGEN
      • 10.4.8.1. Overview
      • 10.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 10.4.8.3. Product Benchmarking
      • 10.4.8.4. Strategic Initiatives
    • 10.4.9. Agilent Technologies
      • 10.4.9.1. Overview
      • 10.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 10.4.9.3. Product Benchmarking
      • 10.4.9.4. Strategic Initiatives
    • 10.4.10. BGI
      • 10.4.10.1. Overview
      • 10.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 10.4.10.3. Product Benchmarking
      • 10.4.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Multiomics Market, By Product & Service, 2018 - 2030 (USD Million)
  • Table 4 Global Multiomics Market, By Type, 2018 - 2030 (USD Million)
  • Table 5 Global Multiomics Market, By Platform, 2018 - 2030 (USD Million)
  • Table 6 Global Multiomics Market, By Application, 2018 - 2030 (USD Million)
  • Table 7 Global Multiomics Market, By End-use, 2018 - 2030 (USD Million)
  • Table 8 Global Multiomics Market, By Region, 2018 - 2030 (USD Million)
  • Table 9 North America Multiomics Market, By Country, 2018 - 2030 (USD Million)
  • Table 10 North America Multiomics Market, By Product & Service, 2018 - 2030 (USD Million)
  • Table 11 North America Multiomics Market, By Type, 2018 - 2030 (USD Million)
  • Table 12 North America Multiomics Market, By Platform, 2018 - 2030 (USD Million)
  • Table 13 North America Multiomics Market, By Application, 2018 - 2030 (USD Million)
  • Table 14 North America Multiomics Market, By End-use, 2018 - 2030 (USD Million)
  • Table 15 U.S. Multiomics Market, By Product & Service, 2018 - 2030 (USD Million)
  • Table 16 U.S. Multiomics Market, By Type, 2018 - 2030 (USD Million)
  • Table 17 U.S. Multiomics Market, By Platform, 2018 - 2030 (USD Million)
  • Table 18 U.S. Multiomics Market, By Application, 2018 - 2030 (USD Million)
  • Table 19 U.S. Multiomics Market, By End-use, 2018 - 2030 (USD Million)
  • Table 20 Canada Multiomics Market, By Product & Service, 2018 - 2030 (USD Million)
  • Table 21 Canada Multiomics Market, By Type, 2018 - 2030 (USD Million)
  • Table 22 Canada Multiomics Market, By Platform, 2018 - 2030 (USD Million)
  • Table 23 Canada Multiomics Market, By Application, 2018 - 2030 (USD Million)
  • Table 24 Canada Multiomics Market, By End-use, 2018 - 2030 (USD Million)
  • Table 25 Europe Multiomics Market, By Country, 2018 - 2030 (USD Million)
  • Table 26 Europe Multiomics Market, By Product & Service, 2018 - 2030 (USD Million)
  • Table 27 Europe Multiomics Market, By Type, 2018 - 2030 (USD Million)
  • Table 28 Europe Multiomics Market, By Platform, 2018 - 2030 (USD Million)
  • Table 29 Europe Multiomics Market, By Application, 2018 - 2030 (USD Million)
  • Table 30 Europe Multiomics Market, By End-use, 2018 - 2030 (USD Million)
  • Table 31 UK Multiomics Market, By Product & Service, 2018 - 2030 (USD Million)
  • Table 32 UK Multiomics Market, By Type, 2018 - 2030 (USD Million)
  • Table 33 UK Multiomics Market, By Platform, 2018 - 2030 (USD Million)
  • Table 34 UK Multiomics Market, By Application, 2018 - 2030 (USD Million)
  • Table 35 UK Multiomics Market, By End-use, 2018 - 2030 (USD Million)
  • Table 36 Germany Multiomics Market, By Product & Service, 2018 - 2030 (USD Million)
  • Table 37 Germany Multiomics Market, By Type, 2018 - 2030 (USD Million)
  • Table 38 Germany Multiomics Market, By Platform, 2018 - 2030 (USD Million)
  • Table 39 Germany Multiomics Market, By Application, 2018 - 2030 (USD Million)
  • Table 40 Germany Multiomics Market, By End-use, 2018 - 2030 (USD Million)
  • Table 41 France Multiomics Market, By Product & Service, 2018 - 2030 (USD Million)
  • Table 42 France Multiomics Market, By Type, 2018 - 2030 (USD Million)
  • Table 43 France Multiomics Market, By Platform, 2018 - 2030 (USD Million)
  • Table 44 France Multiomics Market, By Application, 2018 - 2030 (USD Million)
  • Table 45 France Multiomics Market, By End-use, 2018 - 2030 (USD Million)
  • Table 46 Spain Multiomics Market, By Product & Service, 2018 - 2030 (USD Million)
  • Table 47 Spain Multiomics Market, By Type, 2018 - 2030 (USD Million)
  • Table 48 Spain Multiomics Market, By Platform, 2018 - 2030 (USD Million)
  • Table 49 Spain Multiomics Market, By Application, 2018 - 2030 (USD Million)
  • Table 50 Spain Multiomics Market, By End-use, 2018 - 2030 (USD Million)
  • Table 51 Italy Multiomics Market, By Product & Service, 2018 - 2030 (USD Million)
  • Table 52 Italy Multiomics Market, By Type, 2018 - 2030 (USD Million)
  • Table 53 Italy Multiomics Market, By Platform, 2018 - 2030 (USD Million)
  • Table 54 Italy Multiomics Market, By Application, 2018 - 2030 (USD Million)
  • Table 55 Italy Multiomics Market, By End-use, 2018 - 2030 (USD Million)
  • Table 56 Denmark Multiomics Market, By Product & Service, 2018 - 2030 (USD Million)
  • Table 57 Denmark Multiomics Market, By Type, 2018 - 2030 (USD Million)
  • Table 58 Denmark Multiomics Market, By Platform, 2018 - 2030 (USD Million)
  • Table 59 Denmark Multiomics Market, By Application, 2018 - 2030 (USD Million)
  • Table 60 Denmark Multiomics Market, By End-use, 2018 - 2030 (USD Million)
  • Table 61 Norway Multiomics Market, By Product & Service, 2018 - 2030 (USD Million)
  • Table 62 Norway Multiomics Market, By Type, 2018 - 2030 (USD Million)
  • Table 63 Norway Multiomics Market, By Platform, 2018 - 2030 (USD Million)
  • Table 64 Norway Multiomics Market, By Application, 2018 - 2030 (USD Million)
  • Table 65 Norway Multiomics Market, By End-use, 2018 - 2030 (USD Million)
  • Table 66 Sweden Multiomics Market, By Product & Service, 2018 - 2030 (USD Million)
  • Table 67 Sweden Multiomics Market, By Type, 2018 - 2030 (USD Million)
  • Table 68 Sweden Multiomics Market, By Platform, 2018 - 2030 (USD Million)
  • Table 69 Sweden Multiomics Market, By Application, 2018 - 2030 (USD Million)
  • Table 70 Sweden Multiomics Market, By End-use, 2018 - 2030 (USD Million)
  • Table 71 Asia Pacific Multiomics Market, By Country, 2018 - 2030 (USD Million)
  • Table 72 Asia Pacific Multiomics Market, By Product & Service, 2018 - 2030 (USD Million)
  • Table 73 Asia Pacific Multiomics Market, By Type, 2018 - 2030 (USD Million)
  • Table 74 Asia Pacific Multiomics Market, By Platform, 2018 - 2030 (USD Million)
  • Table 75 Asia Pacific Multiomics Market, By Application, 2018 - 2030 (USD Million)
  • Table 76 Asia Pacific Multiomics Market, By End-use, 2018 - 2030 (USD Million)
  • Table 77 China Multiomics Market, By Product & Service, 2018 - 2030 (USD Million)
  • Table 78 China Multiomics Market, By Type, 2018 - 2030 (USD Million)
  • Table 79 China Multiomics Market, By Platform, 2018 - 2030 (USD Million)
  • Table 80 China Multiomics Market, By Application, 2018 - 2030 (USD Million)
  • Table 81 China Multiomics Market, By End-use, 2018 - 2030 (USD Million)
  • Table 82 Japan Multiomics Market, By Product & Service, 2018 - 2030 (USD Million)
  • Table 83 Japan Multiomics Market, By Type, 2018 - 2030 (USD Million)
  • Table 84 Japan Multiomics Market, By Platform, 2018 - 2030 (USD Million)
  • Table 85 Japan Multiomics Market, By Application, 2018 - 2030 (USD Million)
  • Table 86 Japan Multiomics Market, By End-use, 2018 - 2030 (USD Million)
  • Table 87 India Multiomics Market, By Product & Service, 2018 - 2030 (USD Million)
  • Table 88 India Multiomics Market, By Type, 2018 - 2030 (USD Million)
  • Table 89 India Multiomics Market, By Platform, 2018 - 2030 (USD Million)
  • Table 90 India Multiomics Market, By Application, 2018 - 2030 (USD Million)
  • Table 91 India Multiomics Market, By End-use, 2018 - 2030 (USD Million)
  • Table 92 South Korea Multiomics Market, By Product & Service, 2018 - 2030 (USD Million)
  • Table 93 South Korea Multiomics Market, By Type, 2018 - 2030 (USD Million)
  • Table 94 South Korea Multiomics Market, By Platform, 2018 - 2030 (USD Million)
  • Table 95 South Korea Multiomics Market, By Application, 2018 - 2030 (USD Million)
  • Table 96 South Korea Multiomics Market, By End-use, 2018 - 2030 (USD Million)
  • Table 97 Australia Multiomics Market, By Product & Service, 2018 - 2030 (USD Million)
  • Table 98 Australia Multiomics Market, By Type, 2018 - 2030 (USD Million)
  • Table 99 Australia Multiomics Market, By Platform, 2018 - 2030 (USD Million)
  • Table 100 Australia Multiomics Market, By Application, 2018 - 2030 (USD Million)
  • Table 101 Australia Multiomics Market, By End-use, 2018 - 2030 (USD Million)
  • Table 102 Thailand Multiomics Market, By Product & Service, 2018 - 2030 (USD Million)
  • Table 103 Thailand Multiomics Market, By Type, 2018 - 2030 (USD Million)
  • Table 104 Thailand Multiomics Market, By Platform, 2018 - 2030 (USD Million)
  • Table 105 Thailand Multiomics Market, By Application, 2018 - 2030 (USD Million)
  • Table 106 Thailand Multiomics Market, By End-use, 2018 - 2030 (USD Million)
  • Table 107 Latin America Multiomics Market, By Country, 2018 - 2030 (USD Million)
  • Table 108 Latin America Multiomics Market, By Product & Service, 2018 - 2030 (USD Million)
  • Table 109 Latin America Multiomics Market, By Type, 2018 - 2030 (USD Million)
  • Table 110 Latin America Multiomics Market, By Platform, 2018 - 2030 (USD Million)
  • Table 111 Latin America Multiomics Market, By Application, 2018 - 2030 (USD Million)
  • Table 112 Latin America Multiomics Market, By End-use, 2018 - 2030 (USD Million)
  • Table 113 Brazil Multiomics Market, By Product & Service, 2018 - 2030 (USD Million)
  • Table 114 Brazil Multiomics Market, By Type, 2018 - 2030 (USD Million)
  • Table 115 Brazil Multiomics Market, By Platform, 2018 - 2030 (USD Million)
  • Table 116 Brazil Multiomics Market, By Application, 2018 - 2030 (USD Million)
  • Table 117 Brazil Multiomics Market, By End-use, 2018 - 2030 (USD Million)
  • Table 118 Mexico Multiomics Market, By Product & Service, 2018 - 2030 (USD Million)
  • Table 119 Mexico Multiomics Market, By Type, 2018 - 2030 (USD Million)
  • Table 120 Mexico Multiomics Market, By Platform, 2018 - 2030 (USD Million)
  • Table 121 Mexico Multiomics Market, By Application, 2018 - 2030 (USD Million)
  • Table 122 Mexico Multiomics Market, By End-use, 2018 - 2030 (USD Million)
  • Table 123 Argentina Multiomics Market, By Product & Service, 2018 - 2030 (USD Million),
  • Table 124 Argentina Multiomics Market, By Type, 2018 - 2030 (USD Million)
  • Table 125 Argentina Multiomics Market, By Platform, 2018 - 2030 (USD Million)
  • Table 126 Argentina Multiomics Market, By Application, 2018 - 2030 (USD Million)
  • Table 127 Argentina Multiomics Market, By End-use, 2018 - 2030 (USD Million)
  • Table 128 MEA Multiomics Market, By Country, 2018 - 2030 (USD Million)
  • Table 129 MEA Multiomics Market, By Product & Service, 2018 - 2030 (USD Million)
  • Table 130 MEA Multiomics Market, By Type, 2018 - 2030 (USD Million)
  • Table 131 MEA Multiomics Market, By Platform, 2018 - 2030 (USD Million)
  • Table 132 MEA Multiomics Market, By Application, 2018 - 2030 (USD Million)
  • Table 133 MEA Multiomics Market, By End-use, 2018 - 2030 (USD Million)
  • Table 134 South Africa Multiomics Market, By Product & Service, 2018 - 2030 (USD Million)
  • Table 135 South Africa Multiomics Market, By Type, 2018 - 2030 (USD Million)
  • Table 136 South Africa Multiomics Market, By Platform, 2018 - 2030 (USD Million)
  • Table 137 South Africa Multiomics Market, By Application, 2018 - 2030 (USD Million)
  • Table 138 South Africa Multiomics Market, By End-use, 2018 - 2030 (USD Million)
  • Table 139 UAE Multiomics Market, By Product & Service, 2018 - 2030 (USD Million)
  • Table 140 UAE Multiomics Market, By Type, 2018 - 2030 (USD Million)
  • Table 141 UAE Multiomics Market, By Platform, 2018 - 2030 (USD Million)
  • Table 142 UAE Multiomics Market, By Application, 2018 - 2030 (USD Million)
  • Table 143 UAE Multiomics Market, By End-use, 2018 - 2030 (USD Million)
  • Table 144 Saudi Arabia Multiomics Market, By Product & Service, 2018 - 2030 (USD Million),
  • Table 145 Saudi Arabia Multiomics Market, By Type, 2018 - 2030 (USD Million)
  • Table 146 Saudi Arabia Multiomics Market, By Platform, 2018 - 2030 (USD Million)
  • Table 147 Saudi Arabia Multiomics Market, By Application, 2018 - 2030 (USD Million)
  • Table 148 Saudi Arabia Multiomics Market, By End-use, 2018 - 2030 (USD Million)
  • Table 149 Kuwait Multiomics Market, By Product & Service, 2018 - 2030 (USD Million)
  • Table 150 Kuwait Multiomics Market, By Type, 2018 - 2030 (USD Million)
  • Table 151 Kuwait Multiomics Market, By Platform, 2018 - 2030 (USD Million)
  • Table 152 Kuwait Multiomics Market, By Application, 2018 - 2030 (USD Million)
  • Table 153 Kuwait Multiomics Market, By End-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 Market formulation & validation
  • Fig. 7 Multiomics market segmentation
  • Fig. 8 Market snapshot, 2022
  • Fig. 9 Market trends & outlook
  • Fig. 10 Market driver relevance analysis (current & future impact)
  • Fig. 11 Market restraint relevance analysis (current & future impact)
  • Fig. 12 PESTEL analysis
  • Fig. 13 Porter's five forces analysis
  • Fig. 14 Global multiomics market: Product & Service outlook and key takeaways
  • Fig. 15 Global multiomics market: Product & Service movement analysis
  • Fig. 16 Global multiomics market, for products, 2018 - 2030 (USD Million)
  • Fig. 17 Global multiomics market, for instruments, 2018 - 2030 (USD Million)
  • Fig. 18 Global multiomics market, for consumables, 2018 - 2030 (USD Million)
  • Fig. 19 Global multiomics market, for software, 2018 - 2030 (USD Million)
  • Fig. 20 Global multiomics market, for services, 2018 - 2030 (USD Million)
  • Fig. 21 Global multiomics market: Type outlook and key takeaways
  • Fig. 22 Global multiomics market: Type movement analysis
  • Fig. 23 Global multiomics market, for single- cell multiomics, 2018 - 2030 (USD Million)
  • Fig. 24 Global multiomics market, for bulk multiomics, 2018 - 2030 (USD Million)
  • Fig. 25 Global multiomics market: Platform outlook and key takeaways
  • Fig. 26 Global multiomics market: Platform movement analysis
  • Fig. 27 Global multiomics market, for genomics, 2018 - 2030 (USD Million)
  • Fig. 28 Global multiomics market, for transcriptomics, 2018 - 2030 (USD Million)
  • Fig. 29 Global multiomics market, for proteomics, 2018 - 2030 (USD Million)
  • Fig. 30 Global multiomics market, for metabolomics, 2018 - 2030 (USD Million)
  • Fig. 31 Global multiomics market, for integrated omics platforms, 2018 - 2030 (USD Million)
  • Fig. 32 Global multiomics market: Application outlook and key takeaways
  • Fig. 33 Global multiomics market: Application movement analysis
  • Fig. 34 Global multiomics market, for cell biology, 2018 - 2030 (USD Million)
  • Fig. 35 Global multiomics market, for oncology, 2018 - 2030 (USD Million)
  • Fig. 36 Global multiomics market, for neurology, 2018 - 2030 (USD Million)
  • Fig. 37 Global multiomics market, for immunology, 2018 - 2030 (USD Million)
  • Fig. 38 Global multiomics market: End-use outlook and key takeaways
  • Fig. 39 Global multiomics market: End-use movement analysis
  • Fig. 40 Global multiomics market, for academic and research institutes, 2018 - 2030 (USD Million)
  • Fig. 41 Global multiomics market, for pharmaceutical & biotechnology companies, 2018 - 2030 (USD Million)
  • Fig. 42 Global multiomics market, for others, 2018 - 2030 (USD Million)
  • Fig. 43 Regional marketplace: Key takeaways
  • Fig. 44 Regional outlook, 2022 & 2030
  • Fig. 45 Global multiomics market: Region movement analysis
  • Fig. 46 North America multiomics market, 2018 - 2030 (USD Million)
  • Fig. 47 U.S. multiomics market, 2018 - 2030 (USD Million)
  • Fig. 48 Canada multiomics market, 2018 - 2030 (USD Million)
  • Fig. 49 Europe multiomics market, 2018 - 2030 (USD Million)
  • Fig. 50 Germany multiomics market, 2018 - 2030 (USD Million)
  • Fig. 51 UK multiomics market, 2018 - 2030 (USD Million)
  • Fig. 52 France multiomics market, 2018 - 2030 (USD Million)
  • Fig. 53 Italy multiomics market, 2018 - 2030 (USD Million)
  • Fig. 54 Spain multiomics market, 2018 - 2030 (USD Million)
  • Fig. 55 Denmark multiomics market, 2018 - 2030 (USD Million)
  • Fig. 56 Sweden multiomics market, 2018 - 2030 (USD Million)
  • Fig. 57 Norway multiomics market, 2018 - 2030 (USD Million)
  • Fig. 58 Asia Pacific multiomics market, 2018 - 2030 (USD Million)
  • Fig. 59 Japan multiomics market, 2018 - 2030 (USD Million)
  • Fig. 60 China multiomics market, 2018 - 2030 (USD Million)
  • Fig. 61 India multiomics market, 2018 - 2030 (USD Million)
  • Fig. 62 Australia multiomics market, 2018 - 2030 (USD Million)
  • Fig. 63 South Korea multiomics market, 2018 - 2030 (USD Million)
  • Fig. 64 Thailand multiomics market, 2018 - 2030 (USD Million)
  • Fig. 65 Latin America multiomics market, 2018 - 2030 (USD Million)
  • Fig. 66 Brazil multiomics market, 2018 - 2030 (USD Million)
  • Fig. 67 Mexico multiomics market, 2018 - 2030 (USD Million)
  • Fig. 68 Argentina multiomics market, 2018 - 2030 (USD Million)
  • Fig. 69 Middle East and Africa multiomics market, 2018 - 2030 (USD Million)
  • Fig. 70 South Africa multiomics market, 2018 - 2030 (USD Million)
  • Fig. 71 Saudi Arabia multiomics market, 2018 - 2030 (USD Million)
  • Fig. 72 UAE multiomics market, 2018 - 2030 (USD Million)
  • Fig. 73 Kuwait multiomics market, 2018 - 2030 (USD Million)